ALK-TKI
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia (NCT06643416) | Queen Mary Hospital, Hong Kong | 2024-10-09 |
Track ALK-TKI automatically
Every clearance here is in the API, with alerts when new ones post.